-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Little is known about long-term health-related quality of life (HRQoL) and symptom persistence in patients with indolent non-Hodgkin lymphoma (iNHL) .
Little is known about long-term health-related quality of life (HRQoL) and symptom persistence in patients with indolent non-Hodgkin lymphoma (iNHL) .
Figure 1: Flow chart of the data acquisition process
Figure 1: Flow chart of the data acquisition process
The study included longitudinal surveys of patients diagnosed between 1999 and 2014 and four or more months after diagnosis
Table 1: Patient characteristics by cancer type or normal population mean (SD) or N (%)
Table 1: Patient characteristics by cancer type or normal population mean (SD) or N (%) Table 1: Patient characteristics by cancer type or normal population mean (SD) or N (%)Initial treatment was active surveillance (52%), systemic therapy (31%), or radiotherapy (13%)
Initial treatment was active surveillance (52%), systemic therapy (31%), or radiotherapy (13%)
Figure 2: (A) Fatigue; (B) Neuropathy; and (C) Role Function 10 years after diagnosis
Figure 2: (A) Fatigue; (B) Neuropathy; and (C) Role Function 10 years after diagnosis
Figure 3: Percentage of patients with persistent fatigue, neuropathy, and role dysfunction compared to the normal population
Figure 3: Percentage of patients with persistent fatigue, neuropathy, and role dysfunction compared to the normal population
Scores remained relatively stable with no clinically relevant changes for up to 10 years after diagnosis
Original source:
Original source:Ekels, A ,van de Poll-Franse, LV ,Posthuma, EFM ,Kieffer, J ,Issa, DE , Koster, A , et al.
Ekels, A , van de Poll-Franse, LV , Posthuma, EFM , Kieffer, J , Issa, DE , Koster, A , et al.
Persistent symptoms of fatigue, neuropathy and role-functioning impairment among indolent non-Hodgkin lymphoma survivors: A longitudinal PROFILES registry study .
Br J Haematol .
2022 ; 00 : 1–12 .
https://doi.
org/10.
1111/bjh.
18139 Ekels , A , van de Poll-Franse, LV , Posthuma, EFM , Kieffer, J , Issa, DE , Koster, A, et al.
Persistent symptoms of fatigue, neuropathy and role-functioning impairment among indolent non-Hodgkin lymphoma survivors: A longitudinal PROFILES registry study .
Br J Haematol .
2022 ; 00 : 1–12.
https : //doi.
org/10.
1111 /bjh.
18139 Ekels, A van de Poll-Franse, LV Posthuma, EFM Kieffer, J Issa, DE Koster, A Persistent symptoms of fatigue, neuropathy and role-functioning impairment among indolent non-Hodgkin lymphoma survivors: A longitudinal PROFILES registry study Br J Haematol 2022 00 1 12
Leave a comment here
